Treating Chronic Prostatitis/Chronic Pelvic Cavity Pain Syndrome with4Dose Regimens:Cost-Effec?tiveness Analysis
- VernacularTitle:4种给药方案治疗慢性前列腺炎/慢性盆腔疼痛综合征的成本-效果分析
- Author:
Caihong QU
;
Ning NA
;
Hualing ZHUANG
;
Wenping SHI
- Publication Type:Journal Article
- Keywords:
Chronic prostatitis/chronic pelvic cavity pain syndrome;
Drug treatment;
Cost-effectiveness analysis
- From:
China Pharmacy
1991;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the cost-effectiveness of4dose regimens in treating chronic prostatitis/chronic pelvic cavity pain syndrome(CP/CPPS).METHODS:A total of140patients with CP/CPPS were randomly divided into4groups:Baiyanjing tablets and tamsulosin hydrochloride modified release capsules were administered for Group A;minocycline micro pills and alfuzosin retard tablets for Group B;rexithromycin tablets and doxazosin mesylate controlled release tablets for Group C;and levofloxacin tablets and terazosin tablets for Group D.The cost-effectiveness analysis was performed using pharma?coeconomics.RESULTS:The costs for the Group A,B,C and D were268.8yuan,641.8yuan,660.8yuan and666.4yuan,respectively.The effective rates were71.4%,91.4%,88.6%and91.4%,respectively.The cost-effectiveness ratios were3.76,7.02,7.46and7.29,respectively.The incremental cost-effectiveness ratios of Group B,C and D were18.65,22.79and19.88,respectively as against Group A.CONCLUSION:The treatment cost of CP/CPPS was composed of2parts:an?tibiotics? 1 -receptor blockers.Doctors should make an optimum choice based on patients'previous medication,economic status and physical condition,etc.
